---
title: "Eledon Pharmaceuticals to Present New Long-Term Data from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at American Transplant Congress"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287114656.md"
description: "Eledon will be showcasing updated long-term results from the Phase 2 BESTOW trial of Tegoprubart at the upcoming ATC conference. The trial focuses on leveraging Tegoprubart to prevent rejection in kidney transplant patients. The data to be presented includes significant improvements in rejection rates, with a notable reduction of 30% compared to current standard treatments. This landmark research highlights the potential of Tegoprubart as a promising option in the field of transplant medicine."
datetime: "2026-05-20T20:07:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287114656.md)
  - [en](https://longbridge.com/en/news/287114656.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287114656.md)
---

# Eledon Pharmaceuticals to Present New Long-Term Data from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at American Transplant Congress

Eledon will be showcasing updated long-term results from the Phase 2 BESTOW trial of Tegoprubart at the upcoming ATC conference. The trial focuses on leveraging Tegoprubart to prevent rejection in kidney transplant patients. The data to be presented includes significant improvements in rejection rates, with a notable reduction of 30% compared to current standard treatments. This landmark research highlights the potential of Tegoprubart as a promising option in the field of transplant medicine.

### Related Stocks

- [ELDN.US](https://longbridge.com/en/quote/ELDN.US.md)

## Related News & Research

- [01:00 ETNational Kidney Foundation Innovation Fund Invests in Biohope to Advance Personalized Medicine in Kidney Transplantation](https://longbridge.com/en/news/286359416.md)
- [JAKKS Pacific Debuts First Anime Prototypes at Licensing Expo, Showcasing Hololive Production Line from New Anime Division | JAKK Stock News](https://longbridge.com/en/news/286930790.md)
- [Mexico to reject Royal Caribbean 'Perfect Day' project, minister says](https://longbridge.com/en/news/286969776.md)
- [GRI Bio to Present at A.G.P.’s Annual Healthcare Company Showcase | GRI Stock News](https://longbridge.com/en/news/286777671.md)
- [Akari Therapeutics to Present at A.G.P.’s Annual Healthcare Company Showcase | AKTX Stock News](https://longbridge.com/en/news/286776452.md)